Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds NVDIA CEO Says Employees Given Raises, Says No Layoffs

News

NVDIA CEO Says Employees Given Raises, Says No Layoffs

-Bloomberg Citing Insider

byBenzinga Newsdesk

August 9, 2022

1 minute read

-Bloomberg Citing Insider

Goldman Sachs Initiates Coverage On Aclaris Therapeutics with Buy Rating, Announces Price Target of $25

By Benzinga Newsdesk

December 1, 6:35 AM

Goldman Sachs analyst Corinne Jenkins initiates coverage on Aclaris Therapeutics (NASDAQ:ACRS) with a Buy rating and announces Price Target of $25.

ACRS

Frozen Potato & Fries Company Lamb Weston’s Q3 Highlights: 31% Topline Growth, Earnings Beat, Inflationary Pressures & More

By Shivani Kumaresan

April 6, 10:39 AM

Lamb Weston Holdings Inc (NYSE:LW) reported third-quarter FY23 sales growth of 31% year-on-year to $1.25 billion, beating the consensus of $1.16…

Morgan Stanley Says Executive VP, Chief Operating Officer Jonathan Pruzan Is Retiring From Position Effective Jan. 31

By Michael Horton

January 9, 5:20 PM

-SEC Filing

Hashi Has Ingredients To Insulate It From Slowdown, However It’s Not immune, Analyst Says

By Anusuya Lahiri

December 5, 1:34 PM

Needham analyst Alex Henderson reiterated Hold on HashiCorp, Inc (NASDAQ:HCP). HCP has seen considerable pressure, as it expects maximum margin pain in…

HCP

NVDIA CEO Says Employees Given Raises, Says No Layoffs

Related Posts

Goldman Sachs Initiates Coverage On Aclaris Therapeutics with Buy Rating, Announces Price Target of $25

Frozen Potato & Fries Company Lamb Weston’s Q3 Highlights: 31% Topline Growth, Earnings Beat, Inflationary Pressures & More

Morgan Stanley Says Executive VP, Chief Operating Officer Jonathan Pruzan Is Retiring From Position Effective Jan. 31

Hashi Has Ingredients To Insulate It From Slowdown, However It’s Not immune, Analyst Says